Harvard Medical School, Boston, Massachusetts.
George Washington University, Washington, DC.
JAMA. 2023 Jun 27;329(24):2163-2170. doi: 10.1001/jama.2023.9301.
Anxiety disorders are commonly occurring mental health conditions. They are often unrecognized in primary care settings and substantial delays in treatment initiation occur.
The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in asymptomatic adults.
Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older.
The USPSTF concludes with moderate certainty that screening for anxiety disorders in adults, including pregnant and postpartum persons, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety disorders in older adults.
The USPSTF recommends screening for anxiety disorders in adults, including pregnant and postpartum persons. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in older adults. (I statement).
焦虑障碍是常见的心理健康问题。它们在初级保健环境中经常未被识别，并且在开始治疗时会出现大量延迟。
美国预防服务工作组 (USPSTF) 委托进行了一项系统评价，以评估在无症状成年人中筛查焦虑障碍的益处和危害。
19 岁或以上的无症状成年人，包括孕妇和产后妇女。老年人定义为 65 岁或以上的人。
USPSTF 得出结论，筛查成年人（包括孕妇和产后妇女）的焦虑障碍具有中度净收益，具有中度确定性。USPSTF 得出结论，关于筛查老年人焦虑障碍的证据不足。
USPSTF 建议筛查成年人（包括孕妇和产后妇女）的焦虑障碍。（B 建议）USPSTF 得出结论，目前的证据不足以评估筛查老年人焦虑障碍的利弊平衡。（I 声明）。
